Abbott cannot amend claims in Dexcom patent case, UPC’s Paris division says
MLex Summary: Abbott’s bid to amend its claims in the Dexcom patent infringement case concerning glucose monitoring technology was today rejected by the Unified Patent Court's Paris Local Division. The court...To view the full article, register now.
Already a subscriber? Click here to view full article